Galantamine improves gait performance in patients with Alzheimer's disease.
Assal
Frédéric
F
Allali
Gilles
G
Kressig
Reto W
RW
Herrmann
François R
FR
Beauchet
Olivier
O
D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D001288:Attention / Q000187:drug effects; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005260:Female; D005684:Gait / Q000187:drug effects*; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008609:Mental Status Schedule; D009460:Neurologic Examination / Q000187:drug effects; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*
D002800:Cholinesterase Inhibitors; D018697:Nootropic Agents; D005702:Galantamine